Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,850 across all filing types
Latest filing 2026-04-17 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 92% confidence The document is an announcement of the resolutions and detailed voting results from the company’s 2025 Annual General Meeting (AGM). It lists the meeting convocation, attendance, and the vote counts/results for each agenda item, which matches the definition of “Declaration of Voting Results & Voting Rights Announcements” (code DVA).
2026-04-17 Chinese
关于召开2025年年度股东会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is an official notice (“提示性公告”) of the company’s 2025 Annual General Meeting (AGM), detailing meeting date, location, agenda proposals, voting methods (including proxy voting), registration procedures, and proxy form attachments. It is not the AGM presentation materials themselves (AGM-R), nor is it the actual annual report or earnings release. Rather, it is proprietary meeting solicitation materials sent to shareholders to provide information and request votes, fitting the Proxy Solicitation & Information Statement category (PSI).
2026-04-10 Chinese
关于拟续聘会计师事务所的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding the proposed reappointment of an accounting firm (audit firm) for the upcoming fiscal year 2026. It details the qualifications, integrity, and independence of the audit firm, the audit fees, and the approval process by the board and audit committee. It does not contain any actual financial statements or audit reports but rather informs shareholders and the public about the intention to continue the audit engagement and requests shareholder approval. The document length is 3702 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement related to audit firm appointment but not the audit report itself.
2026-03-27 Chinese
独立董事2025年度述职报告（姜峰）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2025 Annual Work Report" for Yingkang Life Technology Co., Ltd. It details the independent director's background, attendance at board and shareholder meetings, committee work, communication with auditors, and oversight activities during the 2025 fiscal year. The content focuses on the independent director's duties, compliance with laws and regulations, and corporate governance activities rather than financial results or audit opinions. It is a detailed report on the independent director's annual duties and performance, which aligns with Board/Management Information filings that announce changes or reports related to the company's board or senior management. There is no indication that this is a full annual report, audit report, or earnings release. Therefore, the document fits best under Board/Management Information (MANG). The document length (6396 characters) and detailed content support this classification with high confidence.
2026-03-27 Chinese
独立董事2025年度述职报告（陈晓满）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2025 Annual Work Report" for 盈康生命科技股份有限公司. It details the independent director's qualifications, attendance at board and shareholder meetings, committee work, communication with auditors, and oversight activities during the 2025 fiscal year. It includes detailed descriptions of the director's duties, observations on company governance, and specific events such as approval of financial reports and internal audits. The document is a comprehensive report on the independent director's annual duties and activities rather than a financial report, audit report, or announcement. It is not a proxy statement, voting result, or remuneration report. The content aligns with a management or board-related report focusing on governance and director activities. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length (7113 characters) supports it being a full report rather than a brief announcement.
2026-03-27 Chinese
关于举行2025年度报告网上业绩说明会的公告
Investor Presentation Classification · 95% confidence The document is an announcement about the scheduling of an online performance explanation meeting (业绩说明会) related to the company's 2025 Annual Report. It mentions that the 2025 Annual Report and its summary have already been disclosed on March 28, 2026, and invites investors to participate in the online meeting on April 7, 2026. The document does not contain the actual annual report or financial data but serves as a notice for the upcoming investor presentation event. According to the classification rules, announcements about meetings or presentations related to financial reports fall under Investor Presentation (IP) if they focus on financials and strategy, or Report Publication Announcement (RPA) if they announce the release of a report. Since this document is specifically about an online performance explanation meeting (a form of investor presentation) rather than just announcing the report's publication, it fits best under Investor Presentation (IP). The document length is short and it is clearly an announcement for a meeting rather than the report itself.
2026-03-27 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.